Next Article in Journal
Effects of Ginger Straw Silage with Enzymes on Growth Performance, Digestion and Metabolism, Meat Quality and Rumen Microflora Diversity of Laiwu Black Goat
Next Article in Special Issue
Identification and Functional Characterization of the FATP1 Gene from Mud Crab, Scylla paramamosain
Previous Article in Journal
A Review of the Effects of Stress on Dairy Cattle Behaviour
Previous Article in Special Issue
Effects of Dietary Supplementation of Bile Acids on Growth, Glucose Metabolism, and Intestinal Health of Spotted Seabass (Lateolabrax maculatus)
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Proteomics and Its Combined Analysis with Transcriptomics: Liver Fat-Lowering Effect of Taurine in High-Fat Fed Grouper (Epinephelus coioides)

Xiamen Key Laboratory for Feed Quality Testing and Safety Evaluation, Fisheries College of Jimei University, Xiamen 361021, China
*
Author to whom correspondence should be addressed.
Animals 2024, 14(14), 2039; https://doi.org/10.3390/ani14142039
Submission received: 17 June 2024 / Revised: 9 July 2024 / Accepted: 10 July 2024 / Published: 11 July 2024
(This article belongs to the Special Issue Novel Insights into Lipid Metabolism in Aquatic Animals)

Abstract

:

Simple Summary

Taurine has a wide range of biological functions in vertebrates but does not participate in protein synthesis. Recent studies showed taurine exhibits an important role in the regulation of fat metabolism in fish and has the effect of reducing liver fat accumulation in high-fed fish. However, it is still unclear how taurine exerts the effect and the underlying metabolic mechanism of taurine intervention. In this study, we conducted an experiment to investigate the fat-lowering effect of taurine on orange-spotted groupers at the proteomic level. Furthermore, we performed an integrated analysis of transcriptomics and proteomics and excavated the key genes and key proteins involved in the regulation of liver fat metabolism, in an attempt to better understand the intrinsic connection between the transcriptional and translational levels and interpret the trajectories in terms of the biological phenomena in a more comprehensive way after taurine intervention on high-fat fed orange-spotted groupers.

Abstract

In order to understand the intervention effect of taurine on liver fat deposition induced by high fat intake in the orange-spotted grouper (Epinephelus coioides), we performed proteomic analysis and association analysis with previously obtained transcriptomic data. Three isoproteic (47% crude protein) diets were designed to contain two levels of fat and were named as the 10% fat diet (10F), 15% fat diet (15F), and 15% fat with 1% taurine (15FT). The 10F diet was used as the control diet. After 8 weeks of feeding, the 15F diet exhibited comparable weight gain, feed conversion ratio, and hepatosomatic index as the 10F diet, but the former increased liver fat content vs. the latter. Feeding with the 15FT diet resulted in an improvement in weight gain and a reduction in feed conversion ratio, hepatosomatic index, and liver fat content compared with feeding the 15F diet. When comparing liver proteomic data between the 15F and 15FT groups, a total of 133 differentially expressed proteins (DEPs) were identified, of which 51 were upregulated DEPs and 82 were downregulated DEPs. Among these DEPs, cholesterol 27-hydroxylase, phosphatidate phosphatase LPIN, phosphatidylinositol phospholipase C, and 6-phosphofructo-2-kinase were further screened out and were involved in primary bile acid biosynthesis, glycerolipid metabolism, the phosphatidylinositol signaling system, and the AMPK signaling pathway as key DEPs in terms of alleviating liver fat deposition of taurine in high-fat fed fish. With the association analysis of transcriptomic and proteomic data through KEGG, three differentially expressed genes (atp1a, arf1_2, and plcd) and four DEPs (CYP27α1, LPIN, PLCD, and PTK2B) were co-enriched into five pathways related to fat metabolism including primary bile acid synthesis, bile secretion, glycerolipid metabolism, phospholipid D signaling, or/and phosphatidylinositol signaling. The results showed that dietary taurine intervention could trigger activation of bile acid biosynthesis and inhibition of triglyceride biosynthesis, thereby mediating the liver fat-lowering effects in high-fat fed orange-spotted grouper. The present study contributes some novel insight into the liver fat-lowering effects of dietary taurine in high-fat fed groupers.

1. Introduction

As is well known, fat is an essential nutrient for normal growth and development of fish due to its cell structural framework and the fact that it provides fuel for cellular metabolism [1]. Moreover, fat is highly used by fish [2], and the energy utilization efficiency of the digested fat is approximately 80% (64% for digested protein and 58% for digested carbohydrates, respectively) [3]. Fat also has a protein-sparing effect in fish [4,5,6]. As a result, this drives fish farmers to pursue excessive use of fat as an effective energy source in aquafeeds to reduce the consumption of high-quality proteins for fuel, promoting feed utilization [7]. However, the feeding practice of fish has shown that prolonged intake of high-fat feed could cause visceral fat accumulation and fatty liver of fish [8] and, in severe cases, metabolic disorders including fatty liver syndrome [9,10,11]. Therefore, high-fat feed-induced fatty liver, the chronic hepatic disease relevant to nutritional metabolic syndrome, has become one of the important issues in current intensive aquaculture. In order to find an effective prevention and control method to address this threat, there is a need to have a deep understanding of the high-fat feed induced fatty liver in fish and its mechanism.
Taurine, a conditionally indispensable amino acid of farmed fish, displays a valuable potential application in solving this problem [12,13]. It is now clear that taurine has the potential to control fatty liver by relieving fat metabolism disorders of fish with dietary taurine intervention [14,15]. The fat-lowering effect of taurine has been confirmed with effective taurine intervention on fish fed high-fat diets in recent years [12,13,16,17,18,19]. However, it is still unclear how taurine regulates the fat-lowering effect and what role it plays in the fat metabolism of fish. On this issue, our research team conducted a series of studies to investigate the intervention effects of taurine in vitro and in vivo and its regulatory mechanism in high-fat fed orange-spotted grouper (Epinephelus coioides) via transcriptomics, lipidomics, and metabolomics in recent years [20,21,22,23]. Data from our recent lipidomic analysis show that the reduction in liver fat accumulation via dietary taurine addition may be realized through decreasing the contents of TGs containing 18:2n-6 at the sn-2 and sn-3 positions and through promoting the anti-inflammatory capacity of groupers [20]. In another study, the taurine-conjugated BAs have a higher ability to accelerate fat emulsification and absorption than glycine-conjugated and other BAs in the fish species [23]. Moreover, our recent studies in vivo and in vitro using transcriptomics showed that the reduction in liver fat accumulation was attributed to the fact that dietary taurine addition enhanced the synthesis of endogenous taurine in the liver, accelerated BA transport and insulin secretion, thus promoting fatty acid β−oxidation efficiency [21,22].
In the present study, we conducted an experiment regarding taurine intervention in high-fat fed orange-spotted grouper. With these results, we further investigated the fat-lowering effect of taurine on the fish species and elucidated its regulatory mechanism in fat metabolism at the proteomic level. In addition, we performed an integrated analysis of transcriptomics and proteomics based upon our existing transcriptomic and proteomic data and excavated the key genes and key proteins involved in the regulation of liver fat metabolism, in an attempt to better understand the intrinsic connection between the transcriptional and translational levels and interpret the trajectories in terms of the biological phenomena in a more comprehensive way after taurine intervention on high-fat fed orange-spotted grouper [24,25]. This study provides some new insights into the prevention and treatment of nutritional metabolic diseases (fatty liver syndrome) in fish.

2. Materials and Methods

2.1. Experimental Diets

The optimal levels of taurine and fat in feed were 1.0% and 10%, respectively, for the normal growth of orange-spotted grouper in our previous research and those of others [26,27]. Thus, in this experiment, three isoproteic (47% crude protein) semi-purified diets were prepared using casein and gelatin as the main protein ingredients and fish and soy oils and soy lecithin as the major fat ingredients, as previously described in our recent research [22], that is, control diet (10% fat diet), high-fat diet (15% fat diet), and high-fat diet with 1% taurine (15% fat diet with 1% taurine), designated 10F, 15F, and 15FT, respectively (Table 1). The mixed powder feeds were made into sinking pellets, dried, and then stored at −20 °C until use, according to our previous practice [12].

2.2. Growth Trial

The grouper juveniles were obtained from a local hatchery (Zhangpu county, Fujian, China). Prior to the start of the trial, the fish were maintained with a commercial diet (46.1% crude protein and 9.6% crude fat) in a three-week acclimation. A total of 270 groupers with an initial wet weight of about 10.5 g were randomly distributed into nine tanks within a recirculating aquaculture system at a water flow rate of 8 L/min per tank. The groupers of nine tanks were arranged into three treatments, each with triplicate 300 L tanks at a stock density of 30 fish per tank. The groups of triplicate tanks were hand-fed twice daily (8:30 and 18:30) across a feeding period of 8 weeks. Excess feed was collected 30 min after each meal to determine feed intake. During the feeding period, the daily rearing management followed our previous practice [11].

2.3. Sample Collection

At the end of the 8-week feeding trial, five fish were randomly sampled from each tank and sacrificed with an overdose of MS-222 solution (tricaine methanesulfonate, Sigma-Aldrich Shanghai Trading Co., Ltd., Shanghai, China), followed by fish count and batch weighing, and were recorded on a wet weight basis to determine percent weight gain and feed conversion ratio. After completing the weighing, liver was removed to calculate the hepatosomatic index (HSI) and pooled by tank in a tube for determining liver fat content. The same batch of five fish per tank were randomly caught and dissected to aseptically remove livers and were pooled into one tube by tank and then stored at −80 °C for the subsequent extraction of protein.

2.4. Protein Digestion and Peptide TMT Labeling

The volume ratio of liver tissue to lysis buffer SDT in the homogenate was one to four. SDT (4% (w/v) SDS, 100 mM Tris/HCl, pH = 7.6, 0.1M DTT) buffer was used for liver sample lysis and protein extraction. The supernatant (protein solution) was collected. Briefly, 200 μg of protein solution per sample was added to a dithiothreitol solution (DTT, Sigma-Aldrich Shanghai Trading Co., Ltd., Shanghai, China) to make a mixed solution with a final concentration of 5 mmol/L, and the reaction was maintained at 56 °C for 30 min, followed by the addition of iodoacetamide (IAA, Sigma-Aldrich Shanghai Trading Co., Ltd., Shanghai, China), to make a mixed solution with a final concentration of 11 mmol/L, and was then kept at room temperature for 30 min in the dark. The reaction was terminated with triethylamine-carbonate buffer solution (TECS). The amount of protein in the liver sample was quantified with the BCA Protein Assay Kit (Bio-Rad., New York, NY, USA). Protein digestion by trypsin was performed according to the filter-aided sample preparation (FASP) procedure described by Matthias Mann [28]. The digest peptides of each liver sample were desalted on C18 Cartridges (Empore™ SPE Cartridges C18 (standard density), bed ID7 mm, volume 3 mL, Sigma-Aldrich Shanghai Trading Co., Ltd., Shanghai, China) and then concentrated via vacuum centrifugation and reconstituted in 40 µL of 0.1% (v/v) formic acid [29]. The resulting peptide mixture of each liver sample (100 μg) was labeled using TMT (tandem mass tag) reagent according to the manufacturer’s instructions (Thermo Scientific, Xiamen, China).

2.5. High-PH Reversed-Phase Peptide Fractionation

Peptides that have been labeled with the TMT labeling kit, and then mixed in equal parts. The gradient elution separation of aliquots of labeled peptides for each liver sample was performed using the high-pH reversed-phase peptide fractionation kit (Thermo Scientific). The specific procedures refer to Zhang’s description [30]. Firstly, column equilibration was achieved using acetonitrile and 0.1% trifluoroacetic acid. Then, the labeled peptide mixture was added with pure water, followed by centrifugation at low speed for desalination. Finally, step-gradient elution of column-bound peptides was performed with increasing concentrations of high-pH acetonitrile solution. Each eluted peptide sample was then vacuum dried. The lyophilized peptide sample was resolved in 12 μL of 0.1% TFA, and the peptide concentration was determined at OD280.

2.6. LC-MS/MS Analysis

LC-MS/MS data collection refers to the method in [30]. Briefly, a HPLC liquid-phase system (ASY-nLCTM 1200 nm version) was used for the separation of each sample. Buffers A and B were 0.1% formic acid and 0.1% formic acid acetonitrile (84% acetonitrile), respectively. After the column equilibrium was achieved with 95% buffer solution A, the sample was injected via the autosampler to the loading column (Thermo Scientific Acclaim PepMap100, 100 µm × 2 cm, nanoViper C18) and separated through the analytical column (Thermo Scientific EASY column, 10 cm, ID 75 µm, 3 µm, C18-A2) with a flow rate of 300 nL/min.
After completion of chromatographic separation, the peptides were analyzed using a Q-Exactive mass spectrometer (Thermo Scientific). The detection conditions were set as follows: detection mode: positive ion; parent ion scan range: 300–1800 m/z; first order mass spectrometry resolution: 70,000 at 200 m/z; automatic gain control target setting: 100,000; maximum injection time: 50 ms; and dynamic exclusion time: 60 s.
Mass charge ratios of polypeptides and polypeptide fragments were collected according to the following methods: 20 fragment maps were collected for each full scan. The specific parameter settings were as follows: MS2 Activation Type: HCD (higher-energy collision-induced dissociation); isolation window: 2 m/z; resolution of the secondary mass spectrometry: 17,500 at m/z 200; normalized collision energy: 30 eV; and lower fill ratio: 0.1%.

2.7. Database Search and Data Analysis

After completion of the LC-MS/MS analysis, the data in raw files were checked in databases through the software Mascot2.2 (Matrix Science, London, UK) and the software Proteome Discoverer1.4 (Thermo Fisher Scientific, San Jose, CA, USA), and the TMT labeling quantitative analysis was performed. The database search method described by Lin was performed [31]. Briefly, the MS raw data for each sample were searched using the Mascot engine (Matrix Science, London, UK; version 2.2) embedded into Proteome Discoverer 1.4 software (Thermo Electron, San Jose, CA, USA) for identification and quantitation analysis. The Mascot search parameters and instructions are as follows: Max missed cleavages: 2; fixed modifications: Carbamidomethyl (C), iTRAQ 4/8 plex (N-term), iTRAQ 4/8 plex (K), TMT 6/10/16 plex (N-term), TMT 6/10/16 plex (K); variable modifications: oxidation (M), Ox iTRAQ 4/8 plex (Y), TMT 6/10/16 plex (Y); peptide mass tolerance: ±20 ppm; fragment mass tolerance: 0.1 Da; database pattern: decoy; and peptide FDR ≤ 0.01.
The differentially expressed proteins (DEPs) were filtered under the criteria of p-value < 0.05 and fold change (FC) > 1.2-fold for upregulation or less than 0.83 for downregulation [32]. The number of up- and downregulated DEPs of liver in the comparison group was finally obtained.

2.8. Bioinformatics Analysis

Blast2GO (https://www.blast2go.com/) was used to annotate functions of DEPs by GO, which was categorized into three main groups: biological process, molecular function, and cellular component [33]. The DEPs were numbered after GO function annotation of all DEPs [34]. The Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment was performed on DEPs through the database for the KEGG pathway by using the KAAS (KEGG Automatic Annotation Server) online service tool to associate the KEGG ORTHOLOG (KO) numbers of the DEPs to the KEGG pathway [35].

2.9. Parallel Reaction Monitoring (PRM) Analysis

To further verify the reliability of DEPs with TMT analysis, eight randomly selected DEPs were subjected to PRM validation (Table 2). Peptide information was imported into the software Xcalibur4.3 (Thermo Fisher Scientific, San Jose, CA, USA) for PRM method setup. Approximately 1 μg of peptide taken from each sample and 20 fmol of labeled peptide (PRTC: GISNEGQNASIK) were mixed. According to the method in [36], gradient separation of peptides was performed using a high-performance liquid chromatography system with buffer solution A: 0.1% formic acid aqueous solution and buffer solution B: 0.1% formic acid acetonitrile aqueous solution (84% acetonitrile). After separation of peptides, the target peptides were analyzed via PRM mass spectrometry using a Q-Exactive HF mass spectrometer (Thermo Scientific). The specific parameters were as follows: primary MS scan range: 300–1800 m/z; MS resolution: 60,000 (m/z 200); automatic gain control target setting: 3,000,000; maximum injection time: 200 ms; analysis time: 60 min; detection mode: positive ions; 20 MS2 scans at each primary MS scan; PRM scans (MS2 scans), isolation window: 1.6 Th; MS resolution: 30,000 (m/z 200); MS2 activation type: HCD; and normalized collision energy: 27 ev. A total of 9 samples from three groups were subjected to PRM detection, and the PRM raw files were analyzed on the software Skyline 3.5.0 (MacCoss Lab, University of Washington, Seattle, WA, USA).

2.10. Association Analysis of Transcriptomic and Proteomic Data

Based on the transcriptomic data previously obtained in our laboratory and the proteomic data currently obtained, special attention needs to be paid to the DEGs and DEPs enriched through the KEGG database, as well as their related pathways. The association analysis of DEGs and DEPs was performed to identify any common pathways between DEGs and DEPs, or to find pathways that are correlated upstream and downstream, or the pathways that have common metabolites. To this end, a network diagram was constructed to demonstrate the joint participation of DEPs and DEGs in liver fat metabolism after taurine intervention on a high-fat fed grouper.

2.11. Statistical Analysis

Data are presented as means ± SD with n = 3 for growth weight, feed conversion ratio, and liver fat content, while hepatosomatic index data are presented as means ± SD with n = 15. Significant differences among dietary treatments were analyzed with one-way ANOVA and Student–Neuman–Keuls multiple comparison test after data were tested for normality and homogeneity of variance with the Kolmogorov–Smirnov test and Levene’s test in SPSS Statistics 22.0 (SPSS, Michigan Avenue, Chicago, IL, USA). Student’s t-test was applied for comparison between the 15F diet and 15FT diet. The processing of histograms was performed using GraphPad prism 9.0 (San Diego, CA, USA) software. A p-value < 0.05 was considered statistically significant.

3. Results

3.1. Growth Performance and Liver Fat Contents

The growth performance of groupers is shown in Figure 1. There was no difference in weight gain, feed conversion ratio, and hepatosomatic index between the 10F and 15F diets (p > 0.05). However, the 15FT diet resulted in improved weight gain and reduced feed conversion ratio and hepatosomatic index compared with the 15F diet (p < 0.05).
The liver fat content in the 15F diet was significantly higher (p < 0.05) than that in the 10F diet. Fish fed the 15FT diet had lower (p < 0.05) liver fat content compared with those fed the 15F diet, and exhibited comparable liver fat content to those of fish fed the 10F diet (p > 0.05).

3.2. Proteome Profiling

Compared with the 10F diet, a significantly higher liver content was observed in the 15F diet fed fish, and the distinct intervention effect of taurine on the 15FT diet fed fish was also observed. Therefore, we chose 15F and 15FT as the comparison group to analyze the subsequent fat metabolic response after taurine intervention at the proteomic level.
A total of 133 DEPs were filtered by comparing the 15FT and 15F groups, of which 51 proteins were significantly upregulated and 82 proteins were significantly downregulated in the taurine group compared with the non-taurine group (Figure 2).

3.3. Bioinformatics Analysis

GO analysis included biological process, molecular function, and cellular component. As shown in Figure 3, the dominant subcategories were cellular process and metabolic process in the category of biological processes, the binding activity and catalytic activity appeared dominant in the category of molecular function, and the cell and cell part showed the highest percentage in cellular component.
The DEPs were subjected to a KEGG pathway enrichment analysis. Results are shown in Figure 4. In the present study, we mainly focused on metabolic pathways directly related to fat metabolism, such as primary bile acid synthesis and glycerophospholipid metabolism, although many DEPs were enriched in metabolic pathways such as calcium signaling and purine metabolism.

3.4. Protein Pathways Related to Fat Metabolism after Taurine Intervention

After KEGG pathway enrichment analysis of DEPs, the major protein pathways that were involved in fat metabolism included the following: glycerophospholipid metabolism, primary bile acid biosynthesis, phospholipase D signaling pathway, AMPK signaling pathway, etc. The results are shown in Table 3. Thus, the liver protein network related to fat metabolism was constructed by comparing the 15FT diet versus the 15F diet (Figure 5).

3.5. Validation of TMT Results with PRM

Eight DEPs were subjected to PRM analysis to validate the reliability of TMT results. As is shown in Figure 6, dietary taurine addition upregulated the liver expression levels of cholesterol 27-hydroxylase (CYP27A1), 6-phosphofructo-2-kinase (PFKFB1), 4-aminobutyrate aminotransferase (ABAT), and 4a-hydroxytetrahydrobiopterin dehydratase (PCBD) but downregulated the liver expression levels of phosphatidylinositol phospholipase C (PLCD), neutral alpha-glucosidase C (GANC), and ectonucleotide pyrophosphatase (ENPP1_3); however, guanine nucleotide-binding protein G subunit alpha (GNAL) was not affected by dietary taurine addition. There were the same trends of liver expression changes for the above seven proteins subjected to PRM analysis, except GNAL, as those subjected to TMT analysis after high-fat fed fish were intervened with taurine. These results indicated that the high-throughput data through TMT analysis was of high quality and the screening results were reliable in this study.

3.6. Association Analysis of DEGs and DEPs

There were three DEGs (atp1a, plcd, and arf1_2) and four DEPs (CYP27A1, LPIN, PLCD, and PTK2B) that were associated with five KEGG pathways such as primary BA synthesis, bile secretion, glycerolipid metabolism pathway, phospholipase D signaling pathway, and the phosphatidylinositol signaling pathway (Table 4).
As shown in Figure 7, the key protein CYP27A1 and the two key genes atp1a and plcd were upregulated by dietary taurine intervention and were co-enriched in the primary BA synthesis, bile secretion pathways, or/and phosphatidylinositol signaling pathway, promoting BA synthesis and transport. Meanwhile, the three key proteins LPIN, PLCD, and PTK2B and the key gene arf1_2 were downregulated by dietary taurine intervention and were co-enriched in the glycerolipid metabolism pathway, phospholipase D signaling pathway, or/and phosphatidylinositol signaling pathway, resulting in a reduction in TG synthesis. The results showed that dietary taurine addition in 15% high-fat diets could improve liver fat metabolism of groupers through accelerating BA synthesis and transport and inhibiting TG synthesis.

4. Discussion

The results of our present study showed that the growth rate and feed utilization of groupers did not differ as the dietary fat level was increased from 10% to 15%, which indicates that groupers have a high tolerance to dietary fat. Similar results were observed in previous studies with aquatic animals [37] such as black sea bream [38] and large yellow croaker [39]. However, feeding a 15% fat diet led to increased liver fat deposit compared with feeding a 10% fat diet in this study. The increase in liver fat deposit was also observed in high-fat fed fish in many previous studies [8,39,40,41,42,43,44]. Interestingly, our current study showed a significant effect of reducing liver fat, accompanied with improved growth rate and feed utilization after intervention with taurine on 15% fat fed groupers, as evidenced by previous studies with other fish species such as Monopterus albus, California yellowtail, and yellowfin seabream [13,18,45]. Concomitantly, the reduced hepatosomatic index was also observed in the present study and other previous studies after intervention with dietary taurine addition in high-fat fed fish such as California yellowtail, yellowfin seabream, white grouper, turbot, and rice field eel [18,45,46,47,48].
Given the aforementioned effects of dietary taurine on reducing liver fat in fish, there may be a major regulation of taurine in liver fat metabolism at the proteomic level. For this purpose, we conducted proteomic analysis for the first time on the liver fat-lowering effect of dietary taurine in high-fat fed groupers and the possible molecular mechanisms involving fat metabolism. The results showed that a total of 133 DEPs were identified in the comparison between the 15% fat diet group and the 15% fat + 1% taurine group, of which 51 were upregulated and 82 proteins were downregulated. The KEGG pathway analysis on these DEPs showed that the DEPs were mainly enriched in primary bile acid synthesis, glycerophospholipid metabolism, the phosphatidylinositol signaling system, and the AMPK signaling pathway, which was found to be directly related to liver fat metabolism [49,50], and four DEPs (cholesterol 27-hydroxylase, phosphatidate phosphatase LPIN, 6-phosphofructo-2-kinase, and phosphatidylinositol phospholipase C) directly participated in the liver fat metabolism process after dietary taurine intervention in high-fat fed groupers. The findings of the DEPs and signaling pathways will provide a better understanding of the molecular regulation mechanisms of taurine in fat metabolism in fish.
It is clear that bile acids (BAs) are major components of bile and play a vital role in fat metabolism in mammals and fish [39,51]. They can promote fat transport and absorption in the intestine [52]. Taurine-conjugated BAs are the major form of BAs in finfish [14,23,53,54]. The reduction in BAs caused by dietary taurine addition indicates a reduction in their re-absorption in the intestine of finfish [23]. On the other hand, BAs also act as ligands to activate farnesoid X receptors (FXRs) [55,56]. The activated FXRs can reduce lipogenesis and promote fatty acid β-oxidation through inhibiting the transcription of sterol regulatory element-binding protein 1c and carbohydrate response element-binding protein [57]. This is crucial for the regulation of glucose and fat homeostasis and cellular inflammatory pathways [57]. The synthesis of BAs is regulated by the rate-limiting enzymes CYP7A1 and CYP27A1 [51,56], and the resultant taurine-conjugated BAs converted from cholesterol are highly hydrophilic, which enhances the solubility and excretion of cholesterol [58]. CYP27A1 belongs to a family of cytochrome P450 enzymes that converts cholesterol into 25(R)-26- hydroxycholesterol in the alternative pathway of BA synthesis [55,56]. 25(R)-26- hydroxycholesterol can be 7α-hydroxylated to 3β, 7α-dihydroxy-5-cholestanoic acid by oxysterol 7alpha-hydroxylase for synthesis of chenodeoxycholic acid (CDCA) and cholic acid (CA) [56]. CDCA and CA can undergo conjugation with glycine or taurine prior to secretion in the bile to form glycocholic acid, glycochenodeoxycholic acid, taurocholic acid (TCA), and taurochenodeoxycholic acid (TCDCA) [56]. In the present study, CYP27A1 expression was upregulated by dietary taurine addition and was enriched in the primary BA synthesis pathway (Figure 5), which stimulated cholesterol conversion to conjugated BAs in the liver, reflecting the hypocholesterolemic effect of taurine [54], thereby exhibiting a fat-reducing effect.
In the present study, the expression of both phosphatidate phosphatase LPIN (LPIN) protein and phosphatidylinositol phospholipase C (PLCD) protein was downregulated in the 15% fat diet with 1% taurine vs. the 15% fat diet, and they were enriched in glycerolipid metabolism and the phosphatidylinositol signaling system (Figure 5), respectively. In the synthesis of neutral TG in animals, glycerol 3-phosphate is converted into phosphatidic acid through transacylation, which then undergoes dephosphorylation by LPIN to form diacylglycerol (DAG), in turn being converted into TG through transacylation [49]. The LPIN family acts on the third step in the pathway to form DAG by dephosphorylating phosphatidic acid [59]. Lack of LPIN1 expression could affect total cholesterol accumulation in mouse adipose tissue [60,61]. Moreover, PLCD can hydrolyze the phosphatidylinositol 4,5-bisphosphate (PI (4,5) P2) into DAG and inositol 1,4,5-trisphosphate [62]. The downregulated PLCD prohibits the conversion of PI (4,5) P2 to DAG. Therefore, the reduction in TG synthesis in the liver is attributed to the downregulation of expression of LPIN and PLCD in the glycerolipid metabolism pathway and phosphatidylinositol signaling system.
The expression of 6-phosphofructo-2-kinase (PFKFB1) was upregulated in the 15% fat diet with 1% taurine in comparison with the 15% fat diet, and the protein was enriched in the AMPK signaling pathway (Figure 5) in our current study. PFKFB1 is a bifunctional enzyme that catalyzes the synthesis and degradation of fructose 2,6-bisphosphate, acting as an allosteric activator of phosphofructokinase-1 and an inhibitor of fructose 1,6-bisphosphatase, which confers to PFKFB1 a key role in the control of glycolysis and gluconeogenesis [63]. Earlier studies have shown that upregulation of PFKFB1 expression is induced by AMPK activation [64]. AMPK stimulates catabolism by activating glucose uptake, glycolysis (due to PFKFB1 activation), glucose oxidation, and fatty acid oxidation [65]. Thus, the upregulation of PFKFB1 expression in the liver could be triggered by activated AMPK due to dietary taurine addition in the present study. The acetyl CoA carboxylase (ACC) and fatty acid synthase (FAS) are the key enzymes in fat synthesis [1], and were inhibited by activated AMPK in the liver of yellow catfish [66]. Therefore, the fat-reducing effect of dietary taurine in the liver of groupers could be achieved through degradation and utilization of glucose and fat by upregulating PFKFB1 expression through activating the AMPK signaling pathway in the present study.
To validate the reliability of RNA−Seq data, eight randomly selected DEGs in the taurine and high-fat comparison groups were examined using qRT−PCR. The fold changes obtained with qRT−PCR were consistent with the values obtained with RNA−seq for the six selected genes (arf1_2, gk, atp1a, camk, cdo1, and cact), suggesting our RNA-Seq data and the results based on RNA−Seq data analysis were reliable [22]. With association analysis of transcriptomic and proteomic data through KEGG, three DEGs and four DEPs were co-enriched into primary BA synthesis, bile secretion, the glycerolipid metabolism pathway, the phospholipid D signaling pathway, or/and the phosphatidylinositol signaling system. Compared with the 15% fat diet, taurine intervention upregulated the expression of the key protein CYP27α1 and the key gene ATP1α. Moreover, CYP27α1 and ATP1α were enriched into the primary BA synthesis and bile secretion pathways, respectively. The findings indicated that dietary taurine intervention helps promote BA synthesis in the liver and accelerates BA secretion and transport from the liver. It is well known that BAs have a good ability to assist in the digestion of fat in the intestine [52,54,58].
In the meantime, taurine intervention inhibited the expression of the key gene arfi_2 and the key proteins LPIN, PLCD, and PTK2B in the liver of high-fat fed orange-spotted groupers which were co-enriched into the glycerol fat metabolism pathway, the phospholipase D signaling pathway, or/and the phosphatidylinositol signaling system pathway. Although the associated pathways varied, the metabolites of these pathways directly or indirectly point to DAG, which is known to be a precursor substance for TG synthesis [49]. In this sense, the reduction in TG accumulation in the liver was closely associated with the downregulation of key gene and key proteins caused by taurine intervention in high-fat fed groupers. In addition, we previously reported that the reduction in liver fat deposition caused by dietary taurine addition in high-fat fed groupers was the result of the decrease in the content of TG molecules at the lipidomic level [20]. The increased TG molecules may be achieved by simultaneously upregulating the expression of the key gene arfi_2 and the expression of the key proteins LPIN and PLCD after taurine intervention. It is puzzling that we observed that the 15% fat diet with 1% taurine upregulated the expression of the key gene plcd and downregulated the expression of the key protein PLCD compared to the 15% fat diet in the present study, with inconsistent expression results of the same gene and protein. It is precisely because of the complexity of biological metabolic regulation that it is necessary for us to conduct in-depth analysis of the reasons for the inconsistent results in the future.

5. Conclusions

In the present study, new DEPs were identified and were enriched into metabolic pathways related to liver fat metabolism through proteomic analysis and its association with transcriptomic analysis. Three key DEGs (atp1_a, arf1_2, and plcd) and four key DEPs (CYP27α1, LPIN, PLCD, and PTK2B) were identified and co-enriched into the related pathways in liver fat metabolism. The expression changes in these key DEGs and DEPs were associated with increased BA biosynthesis and reduced TG biosynthesis, thereby mediating the effect of reducing fat in the liver after taurine intervention in high-fat fed orange-spotted groupers. To our knowledge, this study presents the first proteomic analysis and its integration analysis with transcriptomics on the fat-reducing effect of dietary taurine in the liver and reveals the close relationship between taurine and liver fat metabolism in the fish species. Further study will be carried out to investigate the functions and roles of these key proteins and key genes as target proteins and genes in the regulation of liver fat metabolism in fish in the future.

Author Contributions

Investigation, methodology, writing-original draft preparation, Y.Z.; investigation, data curation, writing-original draft preparation, F.B.; data curation, formal analysis, R.X.; formal analysis, visualization, M.C.; project administration, writing-review and editing, Y.S.; supervision, funding acquisition, writing-review and editing, J.Y. All authors have read and agreed to the published version of the manuscript.

Funding

This study was supported by funding from the Natural Science Foundation of Xiamen City (Grant No. 3502Z202373027) and the National Natural Science Foundation of China (Grant No. 32072990).

Institutional Review Board Statement

Experimental design and procedures in this study were reviewed and approved by the Animal Ethics Committee of Jimei University, Xiamen, China (Approval number: 2011-58, approval date: 19 December 2011).

Informed Consent Statement

Not applicable.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. He, L.; Qin, Y.; Wang, Y.; Li, D.; Chen, W.; Ye, J. Effects of dietary replacement of fish oil with soybean oil on the growth performance, plasma components, fatty acid composition and lipid metabolism of groupers Epinephelus coioides. Aquac. Nutr. 2021, 27, 1494–1511. [Google Scholar] [CrossRef]
  2. Estefanell, J.; Roo, J.; Guirao, R.; Afonso, J.M.; Fernández-Palacios, H.; Izquierdo, M.; Socorro, J. Efficient utilization of dietary lipids in Octopus vulgaris (Cuvier 1797) fed fresh and agglutinated moist diets based on aquaculture by-products and low price trash species. Aquac. Res. 2012, 44, 93–105. [Google Scholar] [CrossRef]
  3. Phan, L.T.T.; Kals, J.; Masagounder, K.; Mas-Munoz, J.; Schrama, J.W. Energy utilisation efficiencies of digested protein, fat and carbohydrates in striped catfish (Pangasius hypophthalmus) for whole body and fillet growth. Aquaculture 2012, 544, 737083. [Google Scholar] [CrossRef]
  4. Vergara, J.M.; Robainà, L.; Izquierdo, M.; De La Higuera, M. Protein sparing effect of lipids in diets for fingerlings of gilthead sea bream. Fish. Sci. 1996, 62, 624–628. [Google Scholar] [CrossRef]
  5. Skalli, A.; Hidalgo, M.; Abellán, E.; Arizcun, M.; Cardenete, G. Effects of the dietary protein/lipid ratio on growth and nutrient utilization in common dentex (Dentex dentex L.) at different growth stages. Aquaculture 2004, 235, 1–11. [Google Scholar] [CrossRef]
  6. Welengane, E.; Sado, R.Y.; Bicudo, Á.J. Protein-sparing effect by dietary lipid increase in juveniles of the hybrid fish tambatinga (♀ Colossoma macropomum × ♂ Piaractus brachypomus). Aquac. Nutr. 2019, 25, 1272–1280. [Google Scholar] [CrossRef]
  7. Boujard, T.; Gélineau, A.; Covès, D.; Corraze, G.; Dutto, G.; Gasset, E.; Kaushik, S. Regulation of feed intake, growth, nutrient and energy utilisation in European sea bass (Dicentrarchus labrax) fed high fat diets. Aquaculture 2004, 231, 529–545. [Google Scholar] [CrossRef]
  8. Zhou, Y.; Guo, J.; Tang, R.; Ma, H.; Chen, Y.; Lin, S. High dietary lipid level alters the growth, hepatic metabolism enzyme, and anti-oxidative capacity in juvenile largemouth bass Micropterus salmoides. Fish Physiol. Biochem. 2020, 46, 125–134. [Google Scholar] [CrossRef]
  9. Wang, J.; Liang, X.; He, S.; Li, J.; Huang, K.; Zhang, Y.; Huang, D. Lipid deposition pattern and adaptive strategy in response to dietary fat in Chinese perch (Siniperca chuatsi). Nutr. Metab. 2018, 15, 77. [Google Scholar] [CrossRef]
  10. Cao, X.; Dai, Y.; Liu, M.; Yuan, X.; Wang, C.; Huang, Y.; Liu, W.; Jiang, G. High-fat diet induces aberrant hepatic lipid secretion in blunt snout bream by activating endoplasmic reticulum stress-associated IRE1/XBP1 pathway. BBA-Mol. Cell Biol. Lipids 2019, 1864, 213–223. [Google Scholar] [CrossRef]
  11. Jia, R.; Cao, L.; Du, J.; He, Q.; Gu, Z.; Jeney, G.; Xu, P.; Yin, G. Effects of high-fat diet on antioxidative status, apoptosis and inflammation in liver of tilapia (Oreochromis niloticus) via Nrf2, TLRs and JNK pathways. Fish Shellfish. Immunol. 2020, 104, 391–401. [Google Scholar] [CrossRef]
  12. Bai, F.; Niu, X.; Wang, X.; Ye, J. Growth performance, biochemical composition and expression of lipid metabolism related genes in groupers (Epinephelus coioides) are altered by dietary taurine. Aquac. Nutr. 2021, 27, 2690–2702. [Google Scholar] [CrossRef]
  13. Shi, Y.; Zhong, L.; Zhong, H.; Zhang, J.; Che, C.; Fu, G.; Hu, Y.; Mai, K. Taurine supplements in high-fat diets improve survival of juvenile Monopterus albus by reducing lipid deposition and intestinal damage. Aquaculture 2022, 547, 737431. [Google Scholar] [CrossRef]
  14. Kim, S.K.; Kim, K.G.; Kim, K.D.; Kim, K.W.; Son, M.H.; Rust, M.; Johnson, R. Effect of dietary taurine levels on the conjugated bile acid composition and growth of juvenile Korean rockfish Sebastes schlegeli (Hilgendorf). Aquac. Res. 2015, 46, 2768–2775. [Google Scholar] [CrossRef]
  15. Murakami, S.; Ono, A.; Kawasaki, A.; Takenaga, T.; Ito, T. Taurine attenuates the development of hepatic steatosis through the inhibition of oxidative stress in a model of nonalcoholic fatty liver disease in vivo and in vitro. Amino Acids 2018, 50, 1279–1288. [Google Scholar] [CrossRef]
  16. Hernandez, C.; Sanchez-Gutierrez, E.Y.; Ibarra-Castro, L.; Pena, E.; Gaxiola, G.; De La Barca, A.M. Effect of dietary taurine supplementation on growth performance and body composition of snapper, Lutjanus colorado juvenile. Turk. J. Fish. Aquat. Sci. 2018, 18, 1227–1233. [Google Scholar] [CrossRef]
  17. Hoseini, S.; Hosseini, S.; Eskandari, S.; Amirahmadi, M. Effect of dietary taurine and methionine supplementation on growth performance, body composition, taurine retention and lipid status of Persian sturgeon, Acipenser persicus (Borodin, 1897), fed with plant-based diet. Aquac. Nutr. 2018, 24, 324–331. [Google Scholar] [CrossRef]
  18. Garcia-Organista, A.A.; Mata-Sotres, J.A.; Viana, M.T.; Rombenso, A.N. The effects of high dietary methionine and taurine are not equal in terms of growth and lipid metabolism of juvenile California yellowtail (Seriola dorsalis). Aquaculture 2019, 512, 734304. [Google Scholar] [CrossRef]
  19. Aragão, C.; Teodósio, R.; Colen, R.; Richard, N.; Rønnestad, I.; Dias, J.; Conceição, L.E.; Ribeiro, L. Taurine supplementation to plant-based diets improves lipid metabolism in Senegalese sole. Animals 2023, 13, 1501. [Google Scholar] [CrossRef]
  20. Bai, F.; Wang, X.; Niu, X.; Shen, G.; Ye, J. Lipidomic profiling reveals the reducing lipid accumulation effect of dietary taurine in groupers (Epinephelus coioides). Front. Mol. Biosci. 2021, 8, 814318. [Google Scholar] [CrossRef]
  21. Xiao, R.; Feng, H.; Niu, X.; Bai, F.; Ye, J. Effect of taurine intervention on oleic acid-induced primary hepatocyte steatosis in orange-spotted grouper (Epinephelus coioides). Arch. Biol. Sci. 2021, 73, 491–501. [Google Scholar] [CrossRef]
  22. Chen, M.; Bai, F.; Song, T.; Niu, X.; Wang, X.; Wang, K.; Ye, J. Hepatic transcriptome analysis provides new insight into the lipid-reducing effect of dietary taurine in high–fat fed groupers (Epinephelus coioides). Metabolites 2022, 12, 670. [Google Scholar] [CrossRef] [PubMed]
  23. Wang, X.; Bai, F.; Niu, X.; Sun, Y.; Ye, J. The lipid-lowering effect of dietary taurine in orange-spotted groupers (Epinephelus coioides) involves both bile acids and lipid metabolism. Front. Mar. Sci. 2022, 9, 859428. [Google Scholar] [CrossRef]
  24. Estruch, G.; Martínez-Llorens, S.; Tomás-Vidal, A.; Monge-Ortiz, R.; Jover-Cerdá, M.; Brown, P.B.; Peñaranda, D.S. Impact of high dietary plant protein with or without marine ingredients in gut mucosa proteome of gilthead seabream (Sparus aurata, L.). J. Proteom. 2020, 216, 103672. [Google Scholar] [CrossRef] [PubMed]
  25. Boonanuntanasarn, S.; Nakharuthai, C.; Schrama, D.; Duangkaew, R.; Rodrigues, P.M. Effects of dietary lipid sources on hepatic nutritive contents, fatty acid composition and proteome of Nile tilapia (Oreochromis niloticus). J. Proteom. 2019, 192, 208–222. [Google Scholar] [CrossRef] [PubMed]
  26. Luo, Z.; Liu, Y.; Mai, K.; Tian, L.; Liu, D.; Tan, X.; Lin, H. Effect of dietary lipid level on growth performance, feed utilization and body composition of grouper Epinephelus coioides juveniles fed isonitrogenous diets in floating net cages. Aquac. Int. 2005, 13, 257–269. [Google Scholar] [CrossRef]
  27. Zhou, M.; Wang, H.; Ye, J. Responses of growth performance, body composition and tissue free amino acid contents of grouper (Epinephelus coioides) to dietary taurine content. Chin. J. Anim. Nutr. 2015, 27, 785–794. [Google Scholar]
  28. Wiśniewski, J.R.; Zougman, A.; Nagaraj, N.; Mann, M. Universal sample preparation method for proteome analysis. Nat. Methods 2009, 6, 359–362. [Google Scholar] [CrossRef]
  29. Deng, L.; Han, Y.; Tang, C.; Liao, Q.; Li, Z. Label-free mass spectrometry-based quantitative proteomics analysis of serum proteins during early pregnancy in Jennies (Equus asinus). Front. Vet. Sci. 2020, 7, 569587. [Google Scholar] [CrossRef]
  30. Zhang, J.; Cai, X.; Zhang, X.; Lin, L.; Zhao, H.; Liu, X. Proteome analysis and thermal-tolerant protein marker screening in the skin mucus of large yellow croaker Larimichthys crocea. Aquac. Rep. 2021, 21, 100870. [Google Scholar] [CrossRef]
  31. Lin, Y.; Lan, X.; Liu, Z.; Yan, Y.; Zhou, J.; Li, N.; Sun, X.; Li, Q. Activation of ATM-c-IAP1 pathway mediates the protective effects of estradiol in human vascular endothelial cells exposed to intermittent hypoxia. Nat. Sci. Sleep 2019, 11, 357–366. [Google Scholar] [CrossRef] [PubMed]
  32. Zhang, X.; Cai, X.; Liu, X.; Zhao, H.; Song, P.; Zhang, J. Proteomics of liver tissue of large yellow croaker (Larimichthys crocea) under high temperature stress. J. Fish. China 2021, 45, 862–870. [Google Scholar]
  33. Ashburner, M.; Ball, C.A.; Blake, J.A.; Botstein, D.; Butler, H.; Cherry, J.M.; Davis, A.P.; Dolinski, K.; Dwight, S.S.; Eppig, J.T.; et al. Gene ontology: Tool for the unification of biology. Nat. Genet. 2000, 25, 25–29. [Google Scholar] [CrossRef] [PubMed]
  34. Götz, S.; García-Gómez, J.M.; Terol, J.; Williams, T.D.; Nagaraj, S.H.; Nueda, M.J.; Robles, M.; Talón, M.; Dopazo, J.; Conesa, A. High-throughput functional annotation and data mining with the Blast2GO suite. Nucleic Acids Res. 2008, 36, 3420–3435. [Google Scholar] [CrossRef] [PubMed]
  35. Kanehisa, M.; Goto, S.; Sato, Y.; Furumichi, M.; Tanabe, M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res. 2012, 40, D109–D114. [Google Scholar] [CrossRef] [PubMed]
  36. Wang, L.; Leng, L.; Ding, R.; Gong, P.; Liu, C.; Wang, N.; Li, H.; Du, Z.; Cheng, B. Integrated transcriptome and proteome analysis reveals potential mechanisms for differential abdominal fat deposition between divergently selected chicken lines. J. Proteom. 2021, 241, 104242. [Google Scholar] [CrossRef] [PubMed]
  37. Li, L.; Liu, H.-Y.; Xie, S.-Q.; Zhang, P.R.; Yang, Z.-C. Effects of taurine supplementation on growth performance and feed utilization in aquatic animals: A meta-analysis. Aquaculture 2022, 551, 737896. [Google Scholar] [CrossRef]
  38. Jin, M.; Zhu, T.; Tocher, D.R.; Luo, J.; Shen, Y.; Li, X.; Pan, T.; Yuan, Y.; Betancor, M.B.; Jiao, L.; et al. Dietary fenofibrate attenuated high-fat-diet-induced lipid accumulation and inflammation response partly through regulation of pparα and sirt1 in juvenile black seabream (Acanthopagrus schlegelii). Dev. Comp. Immunol. 2020, 109, 103691. [Google Scholar] [CrossRef]
  39. Ding, T.; Xu, N.; Liu, Y.; Du, J.; Xiang, X.; Xu, D.; Liu, Q.; Yin, Z.; Li, J.; Mai, K.; et al. Effect of dietary bile acid (BA) on the growth performance, body composition, antioxidant responses and expression of lipid metabolism-related genes of juvenile large yellow croaker (Larimichthys crocea) fed high-lipid diets. Aquaculture 2020, 518, 734768. [Google Scholar] [CrossRef]
  40. Fei, S.; Xia, Y.; Chen, Z.; Liu, C.; Liu, H.; Han, D.; Jin, J.; Yang, Y.; Zhu, X.; Xie, S. A high-fat diet alters lipid accumulation and oxidative stress and reduces the disease resistance of overwintering hybrid yellow catfish (Pelteobagrus fulvidraco♀ × P. vachelli♂). Aquac. Rep. 2022, 23, 101043. [Google Scholar] [CrossRef]
  41. Guo, J.; Zhou, Y.; Zhao, H.; Chen, W.; Chen, Y.; Lin, S. Effect of dietary lipid level on growth, lipid metabolism and oxidative status of largemouth bass, Micropterus salmoides. Aquaculture 2019, 506, 394–400. [Google Scholar] [CrossRef]
  42. Yin, P.; Xie, S.; Zhuang, Z.; He, X.; Tang, X.; Tian, L.; Liu, Y.; Niu, J. Dietary supplementation of bile acid attenuate adverse effects of high-fat diet on growth performance, antioxidant ability, lipid accumulation and intestinal health in juvenile largemouth bass (Micropterus salmoides). Aquaculture 2021, 531, 735864. [Google Scholar] [CrossRef]
  43. Wang, J.-T.; Liu, Y.-J.; Tian, L.-X.; Mai, K.-S.; Du, Z.-Y.; Wang, Y.; Yang, H. Effect of dietary lipid level on growth performance, lipid deposition, hepatic lipogenesis in juvenile cobia (Rachycentron canadum). Aquaculture 2005, 249, 439–447. [Google Scholar] [CrossRef]
  44. Han, T.; Li, X.; Wang, J.; Hu, S.; Jiang, Y.; Zhong, X. Effect of dietary lipid level on growth, feed utilization and body composition of juvenile giant croaker Nibea japonica. Aquaculture 2014, 434, 145–150. [Google Scholar] [CrossRef]
  45. Dehghani, R.; Oujifard, A.; Mozanzadeh, M.T.; Morshedi, V.; Bagheri, D. Effects of dietary taurine on growth performance, antioxidant status, digestive enzymes activities and skin mucosal immune responses in yellowfin seabream, Acanthopagrus latus. Aquaculture 2020, 517, 734795. [Google Scholar] [CrossRef]
  46. Koven, W.; Peduel, A.; Gada, M.; Nixon, O.; Ucko, M. Taurine improves the performance of white grouper juveniles (Epinephelus aeneus) fed a reduced fish meal diet. Aquaculture 2016, 460, 8–14. [Google Scholar] [CrossRef]
  47. Yun, B.; Ai, Q.; Mai, K.; Xu, W.; Qi, G.; Luo, Y. Synergistic effects of dietary cholesterol and taurine on growth performance and cholesterol metabolism in juvenile turbot (Scophthalmus maximus L.) fed high plant protein diets. Aquaculture 2012, 324, 85–91. [Google Scholar] [CrossRef]
  48. Hu, Y.; Yang, G.; Li, Z.; Hu, Y.; Zhong, L.; Zhou, Q.; Peng, M. Effect of dietary taurine supplementation on growth, digestive enzyme, immunity and resistant to dry stress of rice field eel (Monopterus albus) fed low fish meal diets. Aquac. Res. 2018, 49, 2108–2118. [Google Scholar] [CrossRef]
  49. Yang, H.; Pan, R.; Wang, J.; Zheng, L.; Li, Z.; Guo, Q.; Wang, C. Modulation of the gut microbiota and liver transcriptome by red yeast rice and monascus pigment fermented by purple monascus SHM1105 in rats fed with a high-fat diet. Front. Pharmacol. 2021, 11, 599760. [Google Scholar] [CrossRef] [PubMed]
  50. Zou, C.; Du, L.; Wu, J.; Gan, S.; Li, Q.; Babu, V.S.; Wu, Y.; Lin, L. Saikosaponin d alleviates high-fat-diet induced hepatic steatosis in hybrid grouper (Epinephelus lanceolatus♂ × Epinephelus fuscoguttatus♀) by targeting AMPK/PPARα pathway. Aquaculture 2022, 553, 738088. [Google Scholar] [CrossRef]
  51. Russell, D.W. Fifty years of advances in bile acid synthesis and metabolism. J. Lipid Res. 2009, 50, S120–S125. [Google Scholar] [CrossRef]
  52. Jiang, T.; Xu, C.; Liu, H.; Liu, M.; Wang, M.; Jiang, J.; Zhang, G.; Yang, C.; Huang, J.; Lou, Z. Linderae radix ethanol extract alleviates diet-induced hyperlipidemia by regulating bile acid metabolism through gut microbiota. Front. Pharmacol. 2021, 12, 627920. [Google Scholar] [CrossRef]
  53. Kim, S.-K.; Matsunari, H.; Nomura, K.; Tanaka, H.; Yokoyama, M.; Murata, Y.; Ishihara, K.; Takeuchi, T. Effect of dietary taurine and lipid contents on conjugated bile acid composition and growth performance of juvenile Japanese flounder Paralichthys olivaceus. Fish. Sci. 2008, 74, 875–881. [Google Scholar] [CrossRef]
  54. Xu, H.; Zhang, Q.; Kim, S.-K.; Liao, Z.; Wei, Y.; Sun, B.; Jia, L.; Chi, S.; Liang, M. Dietary taurine stimulates the hepatic biosynthesis of both bile acids and cholesterol in the marine teleost, tiger puffer (Takifugu rubripes). Br. J. Nutr. 2020, 123, 1345–1356. [Google Scholar] [CrossRef]
  55. Chiang, J.Y.; Ferrell, J.M. Bile acid metabolism in liver pathobiology. Gene Expr. 2018, 18, 71–87. [Google Scholar] [CrossRef]
  56. Chiang, J.Y.; Ferrell, J.M. Up to date on cholesterol 7 alpha-hydroxylase (CYP7A1) in bile acid synthesis. Liver Res. 2020, 4, 47–63. [Google Scholar] [CrossRef]
  57. Gusdon, A.M.; Song, K.-x.; Qu, S. Nonalcoholic fatty liver disease: Pathogenesis and therapeutics from a mitochondria-centric perspective. Oxid. Med. Cell. Longev. 2014, 2014, 637027. [Google Scholar] [CrossRef]
  58. Huang, S.; Wu, Q.; Liu, H.; Ling, H.; He, Y.; Wang, C.; Wang, Z.; Lu, Y.; Lu, Y. Alkaloids of dendrobium nobile lindl. Altered hepatic lipid homeostasis via regulation of bile acids. J. Ethnopharmacol. 2019, 241, 111976. [Google Scholar] [CrossRef]
  59. Yang, L.; Liu, Z.; Ou, K.; Wang, T.; Li, Z.; Tian, Y.; Wang, Y.; Kang, X.; Li, H.; Liu, X. Evolution, dynamic expression changes and regulatory characteristics of gene families involved in the glycerophosphate pathway of triglyceride synthesis in chicken (Gallus gallus). Sci. Rep. 2019, 9, 12735. [Google Scholar] [CrossRef]
  60. Phan, J.; Péterfy, M.; Reue, K. Lipin expression preceding peroxisome proliferator-activated receptor-γ is critical for adipogenesis in vivo and in vitro. J. Biol. Chem. 2004, 279, 29558–29564. [Google Scholar] [CrossRef] [PubMed]
  61. Reue, K.; Xu, P.; Wang, X.-P.; Slavin, B.G. Adipose tissue deficiency, glucose intolerance, and increased atherosclerosis result from mutation in the mouse fatty liver dystrophy (fld) gene. J. Lipid Res. 2000, 41, 1067–1076. [Google Scholar] [CrossRef]
  62. Shang, F.-F.; Luo, L.; Yan, J.; Yu, Q.; Guo, Y.; Wen, Y.; Min, X.-L.; Jiang, L.; He, X.; Liu, W. CircRNA_0001449 disturbs phosphatidylinositol homeostasis and AKT activity by enhancing Osbpl5 translation in transient cerebral ischemia. Redox Biol. 2020, 34, 101459. [Google Scholar] [CrossRef]
  63. Iynedjian, P. Molecular physiology of mammalian glucokinase. Cell. Mol. Life Sci. 2009, 66, 27–42. [Google Scholar] [CrossRef]
  64. Smith, T.A.; Zanda, M.; Fleming, I.N. Hypoxia stimulates 18F-fluorodeoxyglucose uptake in breast cancer cells via hypoxia inducible factor-1 and AMP-activated protein kinase. Nucl. Med. Biol. 2013, 40, 858–864. [Google Scholar] [CrossRef]
  65. Ronnett, G.V.; Ramamurthy, S.; Kleman, A.M.; Landree, L.E.; Aja, S. AMPK in the brain: Its roles in energy balance and neuroprotection. J. Neurochem. 2009, 109, 17–23. [Google Scholar] [CrossRef]
  66. Wei, C.-C.; Wu, K.; Gao, Y.; Zhang, L.-H.; Li, D.-D.; Luo, Z. Magnesium reduces hepatic lipid accumulation in yellow catfish (Pelteobagrus fulvidraco) and modulates lipogenesis and lipolysis via PPARA, JAK-STAT, and AMPK pathways in hepatocytes. J. Nutr. 2017, 147, 1070–1078. [Google Scholar] [CrossRef]
Figure 1. Effects of experimental diets on growth performance and liver fat contents of groupers. Groups: 10F, 10% fat diet; 15F, 15% fat diet; 15FT, 15% fat diet with 1% taurine. Weight gain (%) = 100 × (final body weight − initial body weight)/initial body weight; feed conversion ratio = feed intake/wet weight gain; hepatosomatic index (%) = 100 × (liver weight/wet body weight); values for WG, FCR, and liver fat content are presented as the means ± SD (n = 3 tanks); values of hepatosomatic index are presented as the means ± SD (n = 15 fish); values on the bar with different lowercase letter superscripts indicate significant differences (p < 0.05); statistical analysis was performed using one-way ANOVA, followed by Student−Neuman−Keuls multiple comparison test.
Figure 1. Effects of experimental diets on growth performance and liver fat contents of groupers. Groups: 10F, 10% fat diet; 15F, 15% fat diet; 15FT, 15% fat diet with 1% taurine. Weight gain (%) = 100 × (final body weight − initial body weight)/initial body weight; feed conversion ratio = feed intake/wet weight gain; hepatosomatic index (%) = 100 × (liver weight/wet body weight); values for WG, FCR, and liver fat content are presented as the means ± SD (n = 3 tanks); values of hepatosomatic index are presented as the means ± SD (n = 15 fish); values on the bar with different lowercase letter superscripts indicate significant differences (p < 0.05); statistical analysis was performed using one-way ANOVA, followed by Student−Neuman−Keuls multiple comparison test.
Animals 14 02039 g001
Figure 2. Volcano plot for identified and quantified proteins in the present study. Red and blue dots indicate proteins that were differentially expressed, up− or downregulation, respectively, in the 15% fat diet with 1% taurine group versus the 15% fat diet group.
Figure 2. Volcano plot for identified and quantified proteins in the present study. Red and blue dots indicate proteins that were differentially expressed, up− or downregulation, respectively, in the 15% fat diet with 1% taurine group versus the 15% fat diet group.
Animals 14 02039 g002
Figure 3. GO annotation statistics of differentially expressed proteins in 15% fat diet with 1% taurine group versus 15% fat diet group.
Figure 3. GO annotation statistics of differentially expressed proteins in 15% fat diet with 1% taurine group versus 15% fat diet group.
Animals 14 02039 g003
Figure 4. Bubble plot of KEGG pathway enrichment in 15% fat diet with 1% taurine group versus 15% fat diet group.
Figure 4. Bubble plot of KEGG pathway enrichment in 15% fat diet with 1% taurine group versus 15% fat diet group.
Animals 14 02039 g004
Figure 5. Network diagram of proteins related to fat metabolism in the liver of groupers after taurine intervention. CYP27A1, cholesterol 27-hydroxylase; PFKFB1, 6-phosphofructo-2-kinase; ABAT, 4-aminobutyrate aminotransferase; PCBD, 4a-hydroxytetrahydrobiopterin dehydratase; PLCD, phosphatidylinositol phospholipase C; LPIN, phosphatidate phosphatase LPIN; SREBP1, sterol regulatory element-binding protein 1; FAS, fatty acid synthase; ACC1, acyl-CoA carboxylase1; mTOR, mammalian target of rapamycin; PLD1_2, phospholipase D1_2; FBP, fructose-1,6-bisphosphatase I; AMPK, AMP-activated protein kinase; RAPTOR, regulatory-associated protein of mTOR; RHOA, Ras homolog gene family, member A; PTK2B, Protein Tyrosine Kinase 2 Beta; HSD3B7, hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7; AKR1D1, aldo-keto reductase family 1, member D1; CDCA, chenodeoxycholic acid; CA, cholic acid; TCDCA, taurochenodeoxycholic acid; GCDCA, glycochenodeoxycholic acid; TCA, taurocholic acid; GCA, glycocholic acid.
Figure 5. Network diagram of proteins related to fat metabolism in the liver of groupers after taurine intervention. CYP27A1, cholesterol 27-hydroxylase; PFKFB1, 6-phosphofructo-2-kinase; ABAT, 4-aminobutyrate aminotransferase; PCBD, 4a-hydroxytetrahydrobiopterin dehydratase; PLCD, phosphatidylinositol phospholipase C; LPIN, phosphatidate phosphatase LPIN; SREBP1, sterol regulatory element-binding protein 1; FAS, fatty acid synthase; ACC1, acyl-CoA carboxylase1; mTOR, mammalian target of rapamycin; PLD1_2, phospholipase D1_2; FBP, fructose-1,6-bisphosphatase I; AMPK, AMP-activated protein kinase; RAPTOR, regulatory-associated protein of mTOR; RHOA, Ras homolog gene family, member A; PTK2B, Protein Tyrosine Kinase 2 Beta; HSD3B7, hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7; AKR1D1, aldo-keto reductase family 1, member D1; CDCA, chenodeoxycholic acid; CA, cholic acid; TCDCA, taurochenodeoxycholic acid; GCDCA, glycochenodeoxycholic acid; TCA, taurocholic acid; GCA, glycocholic acid.
Animals 14 02039 g005
Figure 6. PRM verification of the expression levels of target proteins in the liver. Values are expressed as the means ± SD (n = 3). Asterisks (*, ** and ***) represent significant differences with p < 0.05, p < 0.01, and p < 0.001, respectively. CYP27A1, cholesterol 27-hydroxylase; PFKFB1, 6-phosphofructo-2-kinase; PLCD, Phosphatidylinositol phospholipase C; GNAL, guanine nucleotide-binding protein G subunit alpha; GANC, neutral alpha-glucosidase C; ABAT, 4-aminobutyrate aminotransferase; ENPP1, ectonucleotide pyrophosphatase; PCBD, 4a-hydroxytetrahydrobiopterin dehydratase.
Figure 6. PRM verification of the expression levels of target proteins in the liver. Values are expressed as the means ± SD (n = 3). Asterisks (*, ** and ***) represent significant differences with p < 0.05, p < 0.01, and p < 0.001, respectively. CYP27A1, cholesterol 27-hydroxylase; PFKFB1, 6-phosphofructo-2-kinase; PLCD, Phosphatidylinositol phospholipase C; GNAL, guanine nucleotide-binding protein G subunit alpha; GANC, neutral alpha-glucosidase C; ABAT, 4-aminobutyrate aminotransferase; ENPP1, ectonucleotide pyrophosphatase; PCBD, 4a-hydroxytetrahydrobiopterin dehydratase.
Animals 14 02039 g006
Figure 7. The network diagram of differentially expressed genes and differentially expressed proteins. CYP27A1, cholesterol 27-hydroxylase; ATP1A, sodium/potassium−transporting ATPase subunit alpha; LIPN, phosphatidate phosphatase LPIN; ARF1_2, ADP−ribosylation factor 1/2; PTK2B, protein tyrosine kinase 2 beta; PLCD, phosphatidylinositol phospholipase C.
Figure 7. The network diagram of differentially expressed genes and differentially expressed proteins. CYP27A1, cholesterol 27-hydroxylase; ATP1A, sodium/potassium−transporting ATPase subunit alpha; LIPN, phosphatidate phosphatase LPIN; ARF1_2, ADP−ribosylation factor 1/2; PTK2B, protein tyrosine kinase 2 beta; PLCD, phosphatidylinositol phospholipase C.
Animals 14 02039 g007
Table 1. Ingredients and proximate composition of experimental diets (on an as−fed basis, %).
Table 1. Ingredients and proximate composition of experimental diets (on an as−fed basis, %).
IngredientsDiets (Fat Level/Taurine Level)
10F (10/0)15F (15/0)15FT (15/1)
Casein:gelatin = 4:1505050
Shrimp meal444
Corn starch252525
Oil blend (fish oil:soy oil = 1:1)61010
Soy lecithin444
Premix0.80.80.8
Ca(H2PO4)2222
Microcrystalline cellulose7.23.22.2
Sodium alginate111
Taurine001
Nutrient level (analyzed values)
Dry matter91.1890.2490.38
Crude protein46.5546.8746.56
Crude lipid10.4414.7914.89
Taurine0.040.040.98
Table 2. Protein expression profile in the TMT detection mode.
Table 2. Protein expression profile in the TMT detection mode.
Protein IDProtein AbbreviationProtein
Description
FCTMT PatternPRM
Pattern
TR5402_c1_g1_ORFCYP27α1Cholesterol 27-hydroxylase1.564upup
TR511_c4_g1_ORFPFKFB16-phosphofructo-2-kinase1.269upup
TR314_c8_g1_ORFPLCDPhosphatidylinositol phospholipase C0.792downdown
TR944_c0_g1_ORF_1ABAT4-aminobutyrate aminotransferase1.393upup
TR1786_c0_g1_ORFGNALGuanine nucleotide-binding protein G subunit alpha0.803downdown
TR1499_c4_g2_ORFGANCNeutral alpha-glucosidase C0.804downnd
TR2721_c0_g1_ORFENPP1_3Ectonucleotide pyrophosphatase0.785downdown
TR244239_c0_g1_ORFPCBD4a-hydroxytetrahydrobiopterin dehydratase1.319upup
Table 3. Identification result of differentially expressed proteins related to fat metabolism in 15% fat diet with 1% taurine group versus 15% fat diet group.
Table 3. Identification result of differentially expressed proteins related to fat metabolism in 15% fat diet with 1% taurine group versus 15% fat diet group.
Protein IDMap NameProtein DescriptionFCp-ValueExpression Pattern
TR5402_c1_g1_ORFPrimary bile acid biosynthesisCholesterol 27-hydroxylase1.5640.0181Up
TR854_c2_g1_ORF_1Glycerolipid metabolism/Glycerophospholipid metabolism/mTOR signaling pathwayPhosphatidate phosphatase LPIN0.8120.0114Down
TR147_c2_g1_ORFGlycerophospholipid metabolism/MAPK signaling pathway-yeastGlycerol-3-phosphate dehydrogenase0.7260.0307Down
TR2191_c0_g1_ORFGlycerophospholipid metabolismPhosphatidylserine sn-1 acylhydrolase0.8160.0393Down
TR969_c0_g1_ORF_1Sphingolipid metabolismCeramide synthetase0.810.0217Down
TR3417_c0_g1_ORFSphingolipid signaling pathwaytranscription factor0.8220.00281Down
TR1786_c0_g1_ORFCalcium signaling pathwayGuanine nucleotide-binding protein G(olf) subunit alpha0.8030.0297Down
TR1499_c4_g2_ORFGalactose metabolism Neutral alpha-glucosidase C0.8040.0303Down
TR61997_c0_g2_ORFSphingolipid signaling pathway/FoxO signaling pathwayMitogen-activated protein kinase0.7960.0119Down
TR43919_c0_g1_ORFPhospholipase D signaling pathway/Calcium signaling pathwayFocal adhesion kinase 20.7970.0053Down
TR52940_c0_g1_ORFmTOR signaling pathwayCalcium binding protein0.7670.0443Down
TR511_c4_g1_ORFAMPK signaling pathway6-phosphofructo-2-kinase1.2690.0153Up
TR2721_c0_g1_ORFStarch and sucrose metabolismEctonucleotide pyrophosphatase0.7850.0359Down
TR244239_c0_g1_ORFFolate biosynthesis4a-hydroxytetrahydrobiopterin dehydratase1.3190.0351Up
TR944_c0_g1_ORF_1beta-Alanine metabolism4-aminobutyrate aminotransferase1.3930.0101Up
TR76930_c0_g1_ORFCitrate cycleMalate dehydrogenase0.8010.0486Down
TR65955_c0_g1_ORFEndocytosisArf-GAP with SH3 domain0.8250.0437Down
TR314_c8_g1_ORFPhosphatidylinositol signaling system/Calcium signaling pathwayPhosphatidylinositol phospholipase C0.7920.0403Down
Table 4. KEGG pathways of the differentially expressed genes (DEGs) and proteins (DEPs) related in liver fat metabolism.
Table 4. KEGG pathways of the differentially expressed genes (DEGs) and proteins (DEPs) related in liver fat metabolism.
Map IDMap NameDEGs/DEPs
ko00120Primary bile acid biosynthesisCYP27α1
ko04976Bile secretionATP1α
ko00561Glycerolipid metabolismLPIN
ko04072Phospholipase D signaling pathwayarf1_2/PTK2B
ko04070Phosphatidylinositol signaling systemplcd/PLCD
DEGs are represented in italics, while DEPs are represented in regular font.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Zhou, Y.; Bai, F.; Xiao, R.; Chen, M.; Sun, Y.; Ye, J. Proteomics and Its Combined Analysis with Transcriptomics: Liver Fat-Lowering Effect of Taurine in High-Fat Fed Grouper (Epinephelus coioides). Animals 2024, 14, 2039. https://doi.org/10.3390/ani14142039

AMA Style

Zhou Y, Bai F, Xiao R, Chen M, Sun Y, Ye J. Proteomics and Its Combined Analysis with Transcriptomics: Liver Fat-Lowering Effect of Taurine in High-Fat Fed Grouper (Epinephelus coioides). Animals. 2024; 14(14):2039. https://doi.org/10.3390/ani14142039

Chicago/Turabian Style

Zhou, Yu, Fakai Bai, Ruyi Xiao, Mingfan Chen, Yunzhang Sun, and Jidan Ye. 2024. "Proteomics and Its Combined Analysis with Transcriptomics: Liver Fat-Lowering Effect of Taurine in High-Fat Fed Grouper (Epinephelus coioides)" Animals 14, no. 14: 2039. https://doi.org/10.3390/ani14142039

APA Style

Zhou, Y., Bai, F., Xiao, R., Chen, M., Sun, Y., & Ye, J. (2024). Proteomics and Its Combined Analysis with Transcriptomics: Liver Fat-Lowering Effect of Taurine in High-Fat Fed Grouper (Epinephelus coioides). Animals, 14(14), 2039. https://doi.org/10.3390/ani14142039

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop